Single-Agent Tislelizumab, an Anti-PD-1 Antibody: Results from a Phase 1 Expansion Cohort in NSCLC Patients

Barlow, P; Jameson, M; Lin, C; Wu, J; Pirzkall, A; Lee, J

JOURNAL OF THORACIC ONCOLOGY, 2019; 14 (10): S721

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索